SUMMARY: This notification is to inform the public that the
DATES: The notification of enforcement discretion was effective on
FOOTNOTE 1 Public Health Emergency Declaration issued by HHS Secretary, pursuant to Section 319 of the Public Health Service Act, on
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION: HHS is informing the public that it is exercising its discretion in how it applies the Privacy, Security, and Breach Notification Rules under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) /2/ during the nationwide public health emergency declared by the Secretary of HHS. /3/
FOOTNOTE 2 Due to the public health emergency posed by COVID-19, the
FOOTNOTE 3 https://www.phe.gov/emergency/news/healthactions/phe/Pages/2019-nCoV.aspx. END FOOTNOTE
During the COVID-19 national emergency, /4/ which also constitutes a nationwide public health emergency, /5/ certain covered health care providers, including some large pharmacy chains, and their business associates may choose to participate in the operation of COVID-19 specimen collection and testing sites (Community-Based Testing Sites, or CBTS). For purposes of this notification, a CBTS includes mobile, drive-through, or walk-up sites that only provide COVID-19 specimen collection or testing services to the public.
FOOTNOTE 4 Presidential Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak (
FOOTNOTE 5 Secretary of HHS
OCR will exercise its enforcement discretion and will not impose penalties for noncompliance with regulatory requirements under the HIPAA Rules against covered health care providers and their business associates in connection with the good faith participation in the operation of a CBTS during the COVID-19 nationwide public health emergency as described below.
II. Who/what is covered by this notification?
This notification applies to all HIPAA covered health care providers and their business associates when such entities are, in good faith, participating in the operation of a CBTS. The operation of a CBTS includes all activities that support the collection of specimens from individuals for COVID-19 testing.
OCR encourages covered health care providers participating in the good faith operation of a CBTS to implement reasonable safeguards to protect the privacy and security of individuals' PHI. Reasonable safeguards include the following:
* Using and disclosing only the minimum PHI necessary except when disclosing PHI for treatment.
* Setting up canopies or similar opaque barriers at a CBTS to provide some privacy to individuals during the collection of samples.
* Controlling foot and car traffic to create adequate distancing at the point of service to minimize the ability of persons to see or overhear screening interactions at a CBTS. (A six foot distance would serve this purpose as well as supporting recommended social distancing measures to minimize the risk of spreading COVID-19.)
* Establishing a "buffer zone" to prevent members of the media or public from observing or filming individuals who approach a CBTS, and posting signs prohibiting filming.
* Using secure technology at a CBTS to record and transmit electronic PHI.
* Posting a Notice of Privacy Practices (NPP), or information about how to find the NPP online, if applicable, in a place that is readily viewable by individuals who approach a CBTS.
Although covered health care providers and business associates are encouraged to implement these reasonable safeguards at a CBTS, OCR will not impose penalties for violations of the HIPAA Privacy, Security, and Breach Notification Rules that occur in connection with the good faith operation of a CBTS.
IV. Who/what is not covered by this notification?
This notification does not apply to health plans or health care clearinghouses when they are performing health plan and clearinghouse functions. To the extent that an entity performs both plan and provider functions, the Notification applies to the entity only in its role as a covered health care provider and only to the extent that it participates in a CBTS.
This notification also does not apply to covered health care providers or their business associates when such entities are performing non-CBTS related activities, including the handling of PHI outside of the operation of a CBTS. Potential HIPAA penalties still apply to all other HIPAA-covered operations of the covered health care provider or business associate, unless otherwise stated by OCR. /6/
FOOTNOTE 6 OCR's Notifications of Enforcement Discretion and other materials relating to the COVID-19 public health emergency are available at https://www.hhs.gov/hipaa/for-professionals/special-topics/hipaa-covid19/index.html. END FOOTNOTE
* A pharmacy that participates in the operation of a CBTS in the parking lot of its retail facility could be subject to a civil money penalty for HIPAA violations that occur inside its retail facility at that location that are unrelated to the CBTS.
* A covered clinical laboratory that has workforce members working on site at a CBTS could be subject to a civil money penalty for HIPAA violations that occur at the laboratory itself.
* A covered health care provider that experiences a breach of PHI in its existing electronic health record system, which includes PHI gathered from the operation of a CBTS, could be subject to a civil money penalty for violations of the HIPAA Breach Notification Rule if it fails to notify all individuals affected by the breach (including individuals whose PHI was created or received from the operation of a CBTS).
V. Collection of Information Requirements
This notification of enforcement discretion creates no legal obligations and no legal rights. Because this document imposes no information collection requirements, it need not be reviewed by the
Notification of enforcement discretion.
CFR Part: "45 CFR Parts 160 and 164"
Citation: "85 FR 29637"
Federal Register Page Number: "29637"
"Rules and Regulations"